136 related articles for article (PubMed ID: 33595947)
1. Novel bone-targeted parathyroid hormone-related peptide antagonists inhibit breast cancer bone metastases.
Ponnapakkam T; Anbalagan M; Stratford RE; Rowan BG; Gensure RC
Anticancer Drugs; 2021 Apr; 32(4):365-375. PubMed ID: 33595947
[TBL] [Abstract][Full Text] [Related]
2. Treatment for chemotherapy-induced alopecia in mice using parathyroid hormone agonists and antagonists linked to a collagen binding domain.
Katikaneni R; Ponnapakkam T; Suda H; Miyata S; Sakon J; Matsushita O; Gensure RC
Int J Cancer; 2012 Sep; 131(5):E813-21. PubMed ID: 22130912
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone-related protein and bone metastases.
Guise TA
Cancer; 1997 Oct; 80(8 Suppl):1572-80. PubMed ID: 9362424
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR
J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902
[TBL] [Abstract][Full Text] [Related]
5. Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231.
Saito H; Tsunenari T; Onuma E; Sato K; Ogata E; Yamada-Okabe H
Anticancer Res; 2005; 25(6B):3817-23. PubMed ID: 16309168
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone-related protein (PTHrP)-(1-139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo.
Guise TA; Yin JJ; Thomas RJ; Dallas M; Cui Y; Gillespie MT
Bone; 2002 May; 30(5):670-6. PubMed ID: 11996903
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling.
Johnson RW; Nguyen MP; Padalecki SS; Grubbs BG; Merkel AR; Oyajobi BO; Matrisian LM; Mundy GR; Sterling JA
Cancer Res; 2011 Feb; 71(3):822-31. PubMed ID: 21189326
[TBL] [Abstract][Full Text] [Related]
8. Structurally diverse N-terminal peptides of parathyroid hormone (PTH) and PTH-related peptide (PTHRP) inhibit the Na+/H+ exchanger NHE3 isoform by binding to the PTH/PTHRP receptor type I and activating distinct signaling pathways.
Azarani A; Goltzman D; Orlowski J
J Biol Chem; 1996 Jun; 271(25):14931-6. PubMed ID: 8663042
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.
Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M
J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525
[TBL] [Abstract][Full Text] [Related]
10. Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts.
Jun AY; Kim HJ; Park KK; Son KH; Lee DH; Woo MH; Chung WY
Invest New Drugs; 2014 Feb; 32(1):1-13. PubMed ID: 23673814
[TBL] [Abstract][Full Text] [Related]
11. Monthly administration of a novel PTH-collagen binding domain fusion protein is anabolic in mice.
Ponnapakkam T; Katikaneni R; Miller E; Ponnapakkam A; Hirofumi S; Miyata S; Suva LJ; Sakon J; Matsushita O; Gensure RC
Calcif Tissue Int; 2011 Jun; 88(6):511-20. PubMed ID: 21512758
[TBL] [Abstract][Full Text] [Related]
12. A single injection of the anabolic bone agent, parathyroid hormone-collagen binding domain (PTH-CBD), results in sustained increases in bone mineral density for up to 12 months in normal female mice.
Ponnapakkam T; Katikaneni R; Suda H; Miyata S; Matsushita O; Sakon J; Gensure RC
Calcif Tissue Int; 2012 Sep; 91(3):196-203. PubMed ID: 22806683
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone-related peptide regulates matrix metalloproteinase-13 gene expression in bone metastatic breast cancer cells.
Ibaragi S; Shimo T; Iwamoto M; Hassan NM; Kodama S; Isowa S; Sasaki A
Anticancer Res; 2010 Dec; 30(12):5029-36. PubMed ID: 21187486
[TBL] [Abstract][Full Text] [Related]
14. Effect of antagonism of the parathyroid hormone (PTH)/PTH-related protein receptor on decidualization in rat uterus.
Williams ED; Major BJ; Martin TJ; Moseley JM; Leaver DD
J Reprod Fertil; 1998 Jan; 112(1):59-67. PubMed ID: 9538330
[TBL] [Abstract][Full Text] [Related]
15. Prevention of breast cancer skeletal metastases with parathyroid hormone.
Swami S; Johnson J; Bettinson LA; Kimura T; Zhu H; Albertelli MA; Johnson RW; Wu JY
JCI Insight; 2017 Sep; 2(17):. PubMed ID: 28878134
[TBL] [Abstract][Full Text] [Related]
16. Cyclic AMP formation in rat bone and kidney cells is stimulated equally by parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34.
Blind E; Raue F; Knappe V; Schroth J; Ziegler R
Exp Clin Endocrinol; 1993; 101(3):150-5. PubMed ID: 8223983
[TBL] [Abstract][Full Text] [Related]
17. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
[TBL] [Abstract][Full Text] [Related]
18. Biologic activities of parathyroid hormone (1-34) and parathyroid hormone-related peptide (1-34) in isolated perfused rat femur.
Lopez-Hilker S; Martin KJ; Sugimoto T; Slatopolsky E
J Lab Clin Med; 1992 Jun; 119(6):738-43. PubMed ID: 1317402
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone (PTH)-related protein is a potent stimulator of osteoclast-like multinucleated cell formation to the same extent as PTH in mouse marrow cultures.
Akatsu T; Takahashi N; Udagawa N; Sato K; Nagata N; Moseley JM; Martin TJ; Suda T
Endocrinology; 1989 Jul; 125(1):20-7. PubMed ID: 2544401
[TBL] [Abstract][Full Text] [Related]
20. The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.
Hiraga T; Williams PJ; Mundy GR; Yoneda T
Cancer Res; 2001 Jun; 61(11):4418-24. PubMed ID: 11389070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
